ArticleAlzheimer's research & therapy2025

Edaravone-Dexborneol slows down pathological progression and cognitive decline via inhibiting S100A9 in APPswe/PS1dE9 mice.

Rui Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.